Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
The risk for ophthalmological conditions in ulcerative colitis: A population-based case-control study. Is silica dust-exposure associated with inflammatory eye disease?
Publication Year: 2024 Source: Acta Ophthalmol PMID: 38738471
No Abstract
Chronic jejuno-colonic fistula and intestinal malabsorption due to multiple magnet ingestions: A case report and systematic review
Publication Year: 2024 Source: Ulus Travma Acil Cerrahi Derg PMID: 38738679
No Abstract
Development and validation of a novel criterion of histologic healing in ulcerative colitis defined by inflammatory cell enumeration in lamina propria mucosa: A multicenter retrospective cohort in China
Publication Year: 2024 Source: Chin Med J (Engl) PMID: 38738696
No Abstract
Impact of a health-system specialty pharmacy on time to upadacitinib initiation
Publication Year: 2024 Source: Am J Health Syst Pharm PMID: 38738829
No Abstract
The relationship between weight change and inflammatory bowel disease. A population-based cohort study, the HUNT study
Publication Year: 2024 Source: Scand J Gastroenterol PMID: 38738865 DOI: 10.1080/00365521.2024.2353099
BACKGROUND: The incidence of inflammatory bowel disease (IBD) is increasing. The prevalence of overweight and obesity is increasing in parallel with IBD and could contribute to IBD development. The aim of this study was to assess the relationship between weight change and the risk for IBD. METHODS: Data gathered from …
Research progress in the treatment of inflammatory bowel disease with natural polysaccharides and related structure-activity relationships
Publication Year: 2024 Source: Food Funct PMID: 38738935 DOI: 10.1039/d3fo04919a
Inflammatory bowel disease (IBD) comprises a group of highly prevalent and chronic inflammatory intestinal tract diseases caused by multiple factors. Despite extensive research into the causes of the disease, IBD's pathogenic mechanisms remain unclear. Moreover, side effects of current IBD therapies restrict their long-term clinical use. In contrast, natural polysaccharides …
Reply to "promising modality for severe ulcerative colitis: infliximab and plant-based diet as first-line (IPF) therapy"
Publication Year: 2024 Source: J Gastroenterol PMID: 38739201
No Abstract
Dual engineered bacteria improve inflammatory bowel disease in mice
Publication Year: 2024 Source: Appl Microbiol Biotechnol PMID: 38739270 DOI: 10.1007/s00253-024-13163-w
Currently, there are many different therapies available for inflammatory bowel disease (IBD), including engineered live bacterial therapeutics. However, most of these studies focus on producing a single therapeutic drug using individual bacteria, which may cause inefficacy. The use of dual drugs can enhance therapeutic effects. However, expressing multiple therapeutic drugs …
[Oral manifestations in Crohn's disease - Two patient cases from the clinic]
Publication Year: 2024 Source: Swiss Dent J PMID: 38739775
No Abstract
SDH, a novel diarylheptane compound, alleviates dextran sulfate sodium (DSS)-induced colitis by reducing Th1/Th2/Th17 induction and regulating the gut microbiota in mice
Publication Year: 2024 Source: Int Immunopharmacol PMID: 38739976
No Abstract
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide